ATE269896T1 - Unterdrückung der abstossung bei xenotransplantation - Google Patents

Unterdrückung der abstossung bei xenotransplantation

Info

Publication number
ATE269896T1
ATE269896T1 AT99956179T AT99956179T ATE269896T1 AT E269896 T1 ATE269896 T1 AT E269896T1 AT 99956179 T AT99956179 T AT 99956179T AT 99956179 T AT99956179 T AT 99956179T AT E269896 T1 ATE269896 T1 AT E269896T1
Authority
AT
Austria
Prior art keywords
suppression
rejection
xenotransplantation
relates
cells
Prior art date
Application number
AT99956179T
Other languages
English (en)
Inventor
Punit Satyavrat Ramrakha
Andrew John Timothy George
Dorian Haskard
Robert Ian Lechler
Anthony Imperial Colle Dorling
Original Assignee
Imp College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imp College Innovations Ltd filed Critical Imp College Innovations Ltd
Application granted granted Critical
Publication of ATE269896T1 publication Critical patent/ATE269896T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2836—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD106
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/80—Immunoglobulins specific features remaining in the (producing) cell, i.e. intracellular antibodies or intrabodies
    • C07K2317/81—Immunoglobulins specific features remaining in the (producing) cell, i.e. intracellular antibodies or intrabodies functional in the endoplasmatic reticulum [ER] or the Golgi apparatus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/04—Fusion polypeptide containing a localisation/targetting motif containing an ER retention signal such as a C-terminal HDEL motif

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Control Of High-Frequency Heating Circuits (AREA)
  • Processes For Solid Components From Exhaust (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
AT99956179T 1998-11-20 1999-11-22 Unterdrückung der abstossung bei xenotransplantation ATE269896T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9825555.7A GB9825555D0 (en) 1998-11-20 1998-11-20 Suppression of xenotransplant rejection
PCT/GB1999/003888 WO2000031126A2 (en) 1998-11-20 1999-11-22 Suppression of xenotransplant rejection

Publications (1)

Publication Number Publication Date
ATE269896T1 true ATE269896T1 (de) 2004-07-15

Family

ID=10842836

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99956179T ATE269896T1 (de) 1998-11-20 1999-11-22 Unterdrückung der abstossung bei xenotransplantation

Country Status (9)

Country Link
US (2) US20050255550A1 (de)
EP (1) EP1131411B1 (de)
JP (1) JP2002531072A (de)
AT (1) ATE269896T1 (de)
AU (1) AU1282900A (de)
DE (1) DE69918327T2 (de)
ES (1) ES2224713T3 (de)
GB (1) GB9825555D0 (de)
WO (1) WO2000031126A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005223617A1 (en) 2004-03-17 2005-09-29 Revivicor, Inc. Tissue products from animals lacking functional alpha 1,3 galactosyl transferase
CA2958259C (en) 2004-10-22 2020-06-30 Revivicor, Inc. Ungulates with genetically modified immune systems
WO2008153725A2 (en) 2007-05-25 2008-12-18 North Carolina State University Viral nanoparticle cell-targeted delivery platform
EP2573112A1 (de) 2007-10-11 2013-03-27 The Hospital For Sick Children Modulation der SIRPa-CD47-Interaktion zur Erhöhung der Transplantatakzeptanz von menschlichen hämatopoetische Stammzellen und Verbindungen dafür
DK2348827T3 (en) 2008-10-27 2015-07-20 Revivicor Inc IMMUNICIPLY COMPROMATED PETS
CA2757842A1 (en) * 2009-04-09 2010-10-14 The Children's Hospital Of Philadelphia Ligand-specific inhibition of attachment of immune cells to implantable biomaterials
WO2011005540A1 (en) 2009-06-22 2011-01-13 Burnham Institute For Medical Research Methods and compositions using peptides and proteins with c-terminal elements
ES2680636T3 (es) 2011-02-14 2018-09-10 Revivicor Inc. Cerdos genéticamente modificados para xenotrasplante de xenoinjertos vascularizados y derivados de los mismos
WO2012118778A1 (en) 2011-02-28 2012-09-07 Sanford-Burnham Medical Research Institute Truncated car peptides and methods and compositions using truncated car peptides
WO2012133954A1 (en) * 2011-03-31 2012-10-04 Kyoto University Novel cardiomyocyte marker
AU2012262488A1 (en) 2011-05-31 2014-01-16 Airware, Inc. Re-calibration of AB NDIR gas sensors
US10179801B2 (en) 2011-08-26 2019-01-15 Sanford-Burnham Medical Research Institute Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides
EP3628047A1 (de) 2017-05-02 2020-04-01 Sanford Burnham Prebys Medical Discovery Institute Tumorassoziiertes monozyten-/makrophagenbindendes peptid und verfahren zur verwendung davon
US12583888B2 (en) 2019-02-04 2026-03-24 University Of Tartu Bi-specific extracellular matrix binding peptides and methods of use thereof
CN114072505B (zh) 2019-04-11 2023-05-30 香港大学 核酸mazzocchio及其制造和使用方法
US20220211018A1 (en) 2020-11-20 2022-07-07 Revivicor, Inc. Multi-transgenic pigs with growth hormone receptor knockout for xenotransplantation
CA3232376A1 (en) 2021-09-20 2023-03-23 Maria KOKKINAKI Multitransgenic pigs comprising ten genetic modifications for xenotransplantation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0178958B1 (ko) * 1992-09-02 1999-03-20 데이비드 제이.엑커 세포 흡착의 올리고누클레오티드 조절
WO1996015780A1 (en) * 1994-11-23 1996-05-30 Isis Pharmaceuticals, Inc. Compositions and methods for preventing and treating allograft rejection
AU7378096A (en) * 1995-09-28 1997-04-17 Alexion Pharmaceuticals, Inc. Porcine cell interaction proteins
FR2751346A1 (fr) * 1996-07-19 1998-01-23 Inst Nat Sante Rech Med Procede de preparation d'organes de mammiferes non humains transgeniques en vue de leur transplantation chez l'homme, et sequences nucleotidiques pour la mise en oeuvre de ce procede

Also Published As

Publication number Publication date
JP2002531072A (ja) 2002-09-24
EP1131411B1 (de) 2004-06-23
EP1131411A2 (de) 2001-09-12
WO2000031126A2 (en) 2000-06-02
WO2000031126A3 (en) 2000-08-24
AU1282900A (en) 2000-06-13
DE69918327D1 (de) 2004-07-29
DE69918327T2 (de) 2006-05-11
US20070157328A1 (en) 2007-07-05
US20050255550A1 (en) 2005-11-17
ES2224713T3 (es) 2005-03-01
GB9825555D0 (en) 1999-01-13

Similar Documents

Publication Publication Date Title
ATE269896T1 (de) Unterdrückung der abstossung bei xenotransplantation
DE69937888D1 (de) Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen
ATE349976T1 (de) Mikrostruktur-stentstruktur
DK1130963T3 (da) Fungicide kombinationer af aktive stoffer
BG103805A (en) Trifluoromethylalkylaminotriazolopyrimidines with fungicidal effect
DK0975219T3 (da) Fungicide kombinationer af aktive stoffer
WO2002060894A3 (en) Sulfonamide lactam inhibitors of factor xa
DE60032102D1 (de) Beschichtung für einen stent
DK1207904T3 (da) Nye kliniske parametre til bestemmelse af hæmatologisk toksicitet forud for radioimmunterapi
WO2006124365A3 (en) Endothelial cell binding coatings for rapid encapsulation of bioerodable stents
WO2005087926A3 (en) Multiple promoter expression cassettes for simultaneous delivery of rnai agents
IT1299317B1 (it) Pacchetto di sigarette.
TR200102773T2 (tr) Alkoksisilan yapısal birimleri olan poliüretan eriyikleri
DE59814262D1 (de) Wandler für teil- oder vollimplantierbare Hörgeräte
TR199801242T2 (xx) Bir antifungal ve bir k�k�rt bile�i�i i�eren bile�imler.
TR200101704T2 (tr) Transplant reddinin engellenmesi için bir MEK inhibitörünün kullanımı
TR199800806T2 (xx) Poliizosiyanat bile�imleri.
ATE410707T1 (de) Kovalent gebundene, hydrophile beschichtungszusammensetzungen für implantate
AU2001253495A1 (en) Treating graft rejection with ccr5 inhibitors
DE60011481D1 (de) Sortiermagazin für die Bevorratung loser Kleinteile
TR200402322T4 (tr) Triptaz inhibitörler
PT1244614E (pt) Inibidores de triptase
WO2005021733A3 (en) Methods and compositions for sirna expression
NO20020193L (no) Pseudomycin N-acyl side-kjede analoger
NO20022138L (no) Kompositt bestanddeler

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1131411

Country of ref document: EP

REN Ceased due to non-payment of the annual fee